Jiangsu Chinagreen Biological Technology Group Co.,Ltd. (SHE:300970)

SHE:300970 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,164	1,032	996.22	751.58	578.08	609.4
Other Revenue	-	-	-	0.02	0	-
Revenue	1,164	1,032	996.22	751.59	578.09	609.4
Revenue Growth (YoY)	18.72%	3.60%	32.55%	30.01%	-5.14%	5.90%
Cost of Revenue	1,074	982.52	870.12	632.47	539.94	443.45
Gross Profit	90.32	49.59	126.1	119.12	38.15	165.95
Selling, General & Admin	69.53	78.37	80.18	49.29	37.25	33.37
Research & Development	14.2	14.61	16.53	14.04	8.62	8.82
Other Operating Expenses	-8.35	-8.14	-7.91	0.53	0.41	0.35
Operating Expenses	75.99	86.44	89.32	64.29	46.72	42.41
Operating Income	14.33	-36.85	36.78	54.83	-8.58	123.54
Interest Expense	-17.16	-11.18	-8.75	-2.69	-3.83	-6.77
Interest & Investment Income	5.74	3.37	9.18	16.7	16.21	7.1
Currency Exchange Gain (Loss)	-	-	-	-	0	-0
Other Non Operating Income (Expenses)	0.33	0.27	1.8	-0.39	-0.2	0.17
EBT Excluding Unusual Items	3.23	-44.4	39.01	68.44	3.6	124.04
Gain (Loss) on Sale of Investments	-	-	-0.17	-0.06	0.24	0.03
Gain (Loss) on Sale of Assets	-1.74	-1.48	-10.89	-1.33	-0.26	-0.01
Asset Writedown	2.45	-1	-3.57	-0.36	-	-0
Other Unusual Items	2.55	2.6	2	13.29	13.21	8.3
Pretax Income	6.49	-44.28	26.37	79.99	16.79	132.36
Income Tax Expense	0.04	0.15	0	2.32	0.51	0.15
Earnings From Continuing Operations	6.46	-44.42	26.37	77.67	16.28	132.21
Minority Interest in Earnings	-2.6	-3.14	3.98	0.59	-0.78	0.29
Net Income	3.86	-47.57	30.35	78.25	15.5	132.5
Net Income to Common	3.86	-47.57	30.35	78.25	15.5	132.5
Net Income Growth	-	-	-61.22%	404.70%	-88.30%	9.80%
Shares Outstanding (Basic)	117	116	117	117	111	102
Shares Outstanding (Diluted)	117	116	117	117	111	102
Shares Change (YoY)	0.74%	-0.61%	-0.06%	5.46%	8.66%	16.56%
EPS (Basic)	0.03	-0.41	0.26	0.67	0.14	1.30
EPS (Diluted)	0.03	-0.41	0.26	0.67	0.14	1.30
EPS Growth	-	-	-61.19%	378.57%	-89.23%	-5.80%
Free Cash Flow	97.83	-130.42	-57.48	-228.07	-121.01	8.13
Free Cash Flow Per Share	0.83	-1.12	-0.49	-1.95	-1.09	0.08
Dividend Per Share	-	-	0.200	0.200	-	0.260
Dividend Growth	-	-	-	-	-	4.00%
Gross Margin	7.76%	4.81%	12.66%	15.85%	6.60%	27.23%
Operating Margin	1.23%	-3.57%	3.69%	7.29%	-1.48%	20.27%
Profit Margin	0.33%	-4.61%	3.05%	10.41%	2.68%	21.74%
Free Cash Flow Margin	8.40%	-12.64%	-5.77%	-30.34%	-20.93%	1.33%
EBITDA	171.97	103.61	154.31	151.79	75.92	199.64
EBITDA Margin	14.77%	10.04%	15.49%	20.20%	13.13%	32.76%
D&A For EBITDA	157.64	140.45	117.53	96.96	84.49	76.09
EBIT	14.33	-36.85	36.78	54.83	-8.58	123.54
EBIT Margin	1.23%	-3.57%	3.69%	7.29%	-1.48%	20.27%
Effective Tax Rate	0.59%	-	-	2.90%	3.02%	0.11%
Revenue as Reported	1,164	1,032	996.22	751.59	578.09	609.4
Advertising Expenses	-	0.45	0.26	0.03	0.89	0.52

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.